Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug design
Biotech
Alnylam pays Inceptive $30M to transform siRNA design
Alnylam has partnered with the person who helped put the âTâ in ChatGPT, paying $30 million to work with Inceptive Nucleics on AI-enabled drug design.
Nick Paul Taylor
Jun 4, 2026 4:13am
Takeda turns to AI drug designer after whittling down R&D focus
Oct 14, 2025 5:00am
Controlled chaos: New method can design disordered proteins
Aug 28, 2024 2:00pm
Verily links up with Sosei Heptares for GPCR drug discovery
Jan 6, 2022 3:30pm
Insilico, 4B Technologies team up for ALS drug discovery
Aug 27, 2021 9:55am
AI drug miner XtalPi strikes gold with $400M VC infusion
Aug 13, 2021 11:26am